Riskpilot← Back to searchSign inGet full accessSANDVIKEN APOTEK AS
ASActiveOrg 994729233Stølegaten 15, 5003 BergenRetail sale of pharmaceutical products · NACE 4773Est. 200926 employees
Revenue 2024
NOK 31,3M
+5% vs 2023
EBITDA margin
3.2%
+171% vs 2023
Equity ratio
14.8%
Financial strength
Net profit 2024
NOK 782K
+180% vs 2023
| Revenue | NOK 31,3M | +5% |
| EBITDA | NOK 1M | +171% |
| Net profit | NOK 782K | +180% |
| Total assets | NOK 6,5M | -10% |
| Equity | NOK 965K | -5% |
| Employees | 26 | — |
Legal name
SANDVIKEN APOTEK AS
Org number
994729233
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
4. november 2009
Share capital
NOK 900 000
Employees
26 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Eierskap og drift av apotek, handel med apotekvarer og relaterte produkteer, aktuelle konsulent og rådgivningstjenester.
Address
Stølegaten 15, 5003 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 21 961 | 24 035 | 25 216 | 29 774 | 31 257 |
| Staff expenses | −3 411 | −3 803 | −4 504 | −5 137 | −5 055 |
| EBITDA | 892 | 1 090 | 467 | 373 | 1 011 |
| Depreciation & amort. | −40 | −28 | −28 | −17 | −8 |
| EBIT | 853 | 1 062 | 439 | 356 | 1 003 |
| Net financials | 0 | −0 | 1 | 0 | 13 |
| Profit before tax | 853 | 1 062 | 440 | 356 | 1 016 |
| Tax | 190 | 232 | 98 | 77 | 234 |
| Net profit | 663 | 830 | 343 | 279 | 782 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 712 | 9 047 | 6 979 | 7 228 | 6 528 |
| Equity | 1 000 | 1 008 | 1 006 | 1 012 | 965 |
| Long-term debt | 935 | 1 796 | 0 | 0 | 350 |
| Short-term debt | 3 776 | 6 243 | 5 973 | 6 216 | 5 213 |
| Total debt | 4 712 | 8 039 | 5 973 | 6 216 | 5 562 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
14.8%
This company
38.2%
Market median
-61% vs market
20202024
Return on equity
81.0%
This company
18.4%
Market median
+340% vs market
20202024
Net profit margin
2.5%
This company
8.1%
Market median
-69% vs market
20202024
Asset turnover
4.79×
This company
1.12×
Market median
+328% vs market
20202024
Debt / equity
5.76×
This company
0.62×
Market median
-829% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TK Deputy Member | Deputy Member | 2025 |
JE Deputy Member | Deputy Member | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mckesson Norway Holding As
SANDVIKEN APOTEK AS Board members of SANDVIKEN APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Kvaal | Deputy Member | 0 companies |
| Jan Erik Helgemo | Deputy Member | 0 companies |
| Håvard Røkke | Chairman | 0 companies |